Role of 99mTc-ubiquicidin 29-41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: A preliminary study

Nuclear Medicine Communications

Volumn 32, Issue 8, 2011, Pages 745-751

  Nazari, Babak ^a,c   Azizmohammadi, Zahra ^a   Rajaei, Morteza ^a   Karami, Mohsen ^a   Javadi, Hamid ^b   Assadi, Majid ^c   Asli, Isa Neshandar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc methylene diphosphonate scan; 99mTc ubiquicidin scan; antimicrobial peptides; orthopedic infection

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UBIQUICIDIN 29-41 TC 99M; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DIAGNOSTIC AGENT; PEPTIDE FRAGMENT; TECHNETIUM 99M UBIQUICIDIN(29 41); TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE INFECTION; BONE SCINTISCANNING; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG UPTAKE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; FEASIBILITY STUDY; INFECTION; MIDDLE AGED; ORTHOPEDICS; RETROSPECTIVE STUDY; SCINTISCANNING; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; INFECTION; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; ORTHOPEDICS; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959973850     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283483964     Document Type: Article

References (29)

1. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, Das S. Clinical evaluation of technetium-99m infection for the localisation of bacterial infection. Eur J Nucl Med 1997; 24:553-556. (Pubitemid 27239215)
2. Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Khan B. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection. J Nucl Med 2004; 45:849-856. (Pubitemid 47618566)
3. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/ inflammation in the new millennium. Eur J Nucl Med 2001; 28:241-252.
4. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001; 1:326-333. (Pubitemid 33586613)
5. Calame W, Welling M, Feitsma HI, Ensing GJ, Pauwels EK. Improved detection of a staphylococcal infection by monomeric and protein A-purified polyclonal human immunoglobulin. Eur J Nucl Med 1993; 20:490-494. (Pubitemid 23232423)
6. Welling M, Feitsma HI, Calame W, Pauwels EK. Localization of a bacterial infection with 99Tcm-labelled human IgG: further improvement with enriched IgG subclass preparations. Nucl Med Commun 1997; 18:1057-1064. (Pubitemid 27523987)
7. Dams ET, Oyen WJ, Boerman OC, Storm G, Laverman P, Kok PJ, et al. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 2000; 41:622-630. (Pubitemid 30207737)
8. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987; 28:1294-1302. (Pubitemid 17156417)
9. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Watherhouse RN. Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 2001; 28:1555-1565.
10. Welling MM, Visentin R, Feitsma HI, Lupetti A, Pauwels EK, Nibbering PH. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41. Nucl Med Biol 2004; 31:503-509. (Pubitemid 38490750)
11. Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 2003; 3:223-229. (Pubitemid 36389185)
12. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001; 42:788-794. (Pubitemid 32453471)
13. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH, et al. Clinical evaluation of antimicrobial peptide [(99m)Tc/tricine/ HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol 2009; 36:199-205.
14. Sepulveda-Mendez J, de Murphy CA, Rojas-Bautista JC, Pedraza-Lopez M. Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun 2010; 31:889-895.
15. Akhtar MS, Khan ME, Khan B, Irfanullah J, Afzal MS, Khan MA, et al. An imaging analysis of (99m)Tc-UBI (29-41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur J Nucl Med Mol Imaging 2008; 35:1056-1064.
16. Park KK, Kim TK, Chang CB, Yoon SW, Park KU. Normative temporal values of CRP and ESR in unilateral and staged bilateral TKA. Clin Orthop Relat Res 2008; 466:179-188. (Pubitemid 351903845)
17. Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology 2007; 12:353-357. (Pubitemid 47180665)
18. Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, et al. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest 2010; 120:3220-3233.
19. Fritz JM, McDonald JR. Osteomyelitis: approach to diagnosis and treatment. Phys Sportsmed 2008; 36:nihpa116823.
20. Donatto KC. Orthopedic management of pyogenic arthritis. Compr Ther 1999; 25:411-417. (Pubitemid 29455773)
21. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 2005; 46:567-573. (Pubitemid 41716399)
22. Fischman AJ, Rauh D, Solomon H, Babich JW, Tompkins RG, Kroon D, et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med 1993; 34:2130-2134. (Pubitemid 24002956)
23. Vinjamuri S, Hall AV, Solanki KK, Bomanji J, Siraj Q, O'Shaughnessy E, et al. Comparison of 99mTc infection imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347:233-235.
24. Larikka MJ, Ahonen AK, Niemela O, Junila JA, Hämä lä inen MM, Britton K, Syrjä lä HP. Comparison of 99mTc ciprofloxacin, 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun 2002; 23:655-661. (Pubitemid 34748005)
25. Knight LC. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med 2003; 47:279-291. (Pubitemid 38418048)
26. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, Arteaga De Murphy C, Herrera-Rodríguez R, Mitsoura E, et al. Biokinetics of (99m)Tc-UBI 29-41 in humans. Nucl Med Biol 2004; 31:373-379.
27. Arteaga de Murphy C, Gemmel F, Balter J. Clinical trial of specific imaging of infections. Nucl Med Commun 2010; 31:726-733.
28. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CP, Lupetti A, Pauwels EK. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004; 45:321-326. (Pubitemid 47618657)
29. Nibbering PH, Welling MM, Paulusma-Annema A, Van den Barselaar MT, Pauwels EKJ. Monitoring the efficacy of antibacterial treatments of infections with 99mTc-labelled antimicrobial peptides (abstract). Nucl Med Commun 2000; 21:575-576.